University of California San Francisco
Give to UCSF
Women whose breasts are composed largely of glandular tissue, rather than fat, have an amplified risk of breast cancer, which exceeds the impact of other widely known risks on a population level.
Stories about sensory processing disorder, videos about “zombie” cancer cells, and news about the effects of caffeine and alcohol on the heart were among the topics that most engaged our readers in 2016.
A group that includes UCSF, the City and County of San Francisco, and health care and community organizations has launched the San Francisco Cancer Initiative, a major public health effort to reduce cancer in San Francisco.
A team of researchers led by UCSF scientists has identified a new drug target for triple-negative breast cancer.
Early-stage breast cancer patients whose tumors carry genetic markers associated with a low risk of disease recurrence may not need to undergo chemotherapy, suggests a new study that employed a test devised by a UCSF researcher.
The ideal interval for breast cancer screening depends on combined assessments of each woman’s breast cancer risk and her breast density, according to a new study led by UCSF and University of Wisconsin researchers.
A previously unidentifiable type of low-grade inflammation may explain why common anti-inflammatory drugs such as aspirin have shown promise against some types of cancer – even when patients don’t display typical signs of inflammation.
Three UCSF faculty members participated in the White House Cancer Moonshot Summit, at which the University of California committed to a new transformative model for health care delivery for breast cancer patients.
Time magazine has named internationally renowned breast cancer oncologist Laura Esserman to the 2016 TIME 100, the magazine’s annual list of the 100 most influential people in the world.
The new UCSF Center for BRCA Research – which spans basic and translational research, clinical care and education – provides a one-stop resource for patients and individuals who carry BRCA1 and BRCA2 mutations.
